SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
274 hedge funds and large institutions have $6.93B invested in Sage Therapeutics in 2018 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 95 increasing their positions, 90 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
274
Holders Change
+6
Holders Change %
+2.24%
% of All Funds
6.27%
Holding in Top 10
7
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-50%
% of All Funds
0.16%
New
43
Increased
95
Reduced
90
Closed
33
Calls
$63.1M
Puts
$62.1M
Net Calls
+$1.02M
Net Calls Change
-$2.15M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
$134M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$577M |
| 3 |
Invesco
Atlanta,
Georgia
|
$81.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$25.3M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
$69.8M |
Top Sellers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$42.5M |
| 2 |
Goldman Sachs
New York
|
$31.7M |
| 3 |
Renaissance Technologies
New York
|
$396K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
$0 |
| 5 |
D.E. Shaw & Co
New York
|
$218K |
